Logo
Please use this identifier to cite or link to this item: http://20.198.91.3:8080/jspui/handle/123456789/7650
Full metadata record
DC FieldValueLanguage
dc.contributor.advisorJha, Tarun-
dc.contributor.authorKundu, Ritabrata-
dc.date.accessioned2025-02-28T10:15:43Z-
dc.date.available2025-02-28T10:15:43Z-
dc.date.issued2022-
dc.date.submitted2022-
dc.identifier.otherDC4970-
dc.identifier.urihttp://20.198.91.3:8080/jspui/handle/123456789/7650-
dc.format.extent68p.en_US
dc.language.isoenen_US
dc.publisherJadavpur University, Kolkata, West Bengalen_US
dc.subjectCanceren_US
dc.subjectNeoplasmic conditionsen_US
dc.subjectCarcinogenesisen_US
dc.subjectProto-oncogeneen_US
dc.subjectLymphomaen_US
dc.subjectChemotherapyen_US
dc.subjectCancer pharmacologyen_US
dc.titleA quantitative structural analysis of hydroxamate-based HDAC1 inhibitors: Identification of promising structural contributors for the development of effective anticancer agenten_US
dc.typeTexten_US
dc.departmentPharmaceutical Technologyen_US
Appears in Collections:Dissertations

Files in This Item:
File Description SizeFormat 
M. Pharm (Pharmaceutical Technology) Ritabrata Kundu.pdf1.74 MBAdobe PDFView/Open


Items in IR@JU are protected by copyright, with all rights reserved, unless otherwise indicated.